title: Rituximab as first-line therapy for acquired haemophilia A: a single-centre 10-year experience.
authors.affiliation: Department of Internal Medicine, National Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Université Paris Descartes, Paris, France.
authors.forename: B
authors.initials: B
authors.lastname: Rossi
authors.affiliation: Department of Internal Medicine, National Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Université Paris Descartes, Paris, France.
authors.forename: P
authors.initials: P
authors.lastname: Blanche
authors.affiliation: Centre des hémophiles, Hôpital Cochin, Assistance Publique Hôpitaux de Paris Université Paris Descartes, Paris, France.
authors.forename: V
authors.initials: V
authors.lastname: Roussel-Robert
authors.affiliation: Department of Internal Medicine, National Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Université Paris Descartes, Paris, France.
authors.forename: A
authors.initials: A
authors.lastname: Berezné
authors.affiliation: Centre des hémophiles, Hôpital Cochin, Assistance Publique Hôpitaux de Paris Université Paris Descartes, Paris, France.
authors.forename: S
authors.initials: S
authors.lastname: Combe
authors.affiliation: Department of Hematology, Hôpital Saint-Antoine, Assistance Publique Hôpitaux de Paris, Université Pierre et Marie Curie, Paris, France.
authors.forename: P
authors.initials: P
authors.lastname: Coppo
authors.affiliation: Department of Internal Medicine, National Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Université Paris Descartes, Paris, France.
authors.forename: L
authors.initials: L
authors.lastname: Guillevin
authors.affiliation: Department of Internal Medicine, National Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Université Paris Descartes, Paris, France.
authors.forename: C
authors.initials: C
authors.lastname: Le Jeunne
authors.affiliation: Department of Internal Medicine, National Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Université Paris Descartes, Paris, France.
authors.forename: L
authors.initials: L
authors.lastname: Mouthon
authors.affiliation: Centre des hémophiles, Hôpital Cochin, Assistance Publique Hôpitaux de Paris Université Paris Descartes, Paris, France.
authors.forename: N
authors.initials: N
authors.lastname: Ounnoughene
authors.affiliation: Centre des hémophiles, Hôpital Cochin, Assistance Publique Hôpitaux de Paris Université Paris Descartes, Paris, France.
authors.forename: N
authors.initials: N
authors.lastname: Stieltjes
authors.affiliation: Department of Internal Medicine, National Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Université Paris Descartes, Paris, France.
authors.forename: M
authors.initials: M
authors.lastname: Groh
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D057134:Antibodies, Neutralizing / Q000097:blood; D003520:Cyclophosphamide / Q000627:therapeutic use; D005169:Factor VIII / Q000032:analysis; D005260:Female; D006467:Hemophilia A / Q000188:drug therapy*; D006470:Hemorrhage / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D012189:Retrospective Studies; D000069283:Rituximab / Q000627:therapeutic use*; D055815:Young Adult
chemical_list: D000305:Adrenal Cortex Hormones; D057134:Antibodies, Neutralizing; D007166:Immunosuppressive Agents; D000069283:Rituximab; D003520:Cyclophosphamide; D005169:Factor VIII